Global Perioral Dermatitis Treatment Market to grow with a CAGR of 7.10%
Increasing healthcare infrastructure and
a supportive regulatory environment are the major drivers for the Global Perioral
Dermatitis Treatment Market.
According to TechSci Research report, “Global
Perioral Dermatitis Treatment Market Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028”, Global Perioral Dermatitis Treatment
Market has valued at USD 115.30 million in 2022 and is anticipated to witness
an impressive growth in the forecast period with a CAGR of 7.10% through
2028. This can be due to collaborations
and partnerships among leading companies with a diverse approach to merge the
expertise of individual companies and to strengthen their position in the
market. There are some indirect ways in which the rising awareness of skin
health and aesthetics can impact the demand for perioral dermatitis treatment. Some
cosmetic and skincare products, particularly those containing topical steroids,
can trigger or exacerbate perioral dermatitis. As people become more conscious
of their skincare routines and the products they use, they may be more likely
to seek treatment for any adverse skin reactions, including perioral
dermatitis. Individuals
seeking aesthetic care and desiring clear, healthy skin may be more motivated
to address skin conditions like perioral dermatitis, as it can affect their
appearance. Clear skin is a common aesthetic goal. Patients interested in
aesthetic treatments may prefer non-invasive or minimally invasive options,
which align with the topical or oral treatments commonly used to manage
perioral dermatitis. The preference for less invasive treatments may contribute
to the demand for such options. Educational efforts by dermatologists, skincare
professionals, and healthcare organizations can raise awareness not only about
cosmetic treatments but also about skin health and the management of conditions
like perioral dermatitis.
Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on " Global Perioral Dermatitis Treatment Market.”
Perioral dermatitis is a rash that impacts the
region around the mouth, leading to inflammation. This rash can extend upward
towards the nose or even involve the area around the eyes. A prevalent symptom
of this condition is the presence of a scaly or red bumpy rash. On darker skin,
the lesions may appear hyperpigmented or brown in color. Antibiotics, whether
administered orally or topically, can be beneficial for a few weeks. Azelaic
acid is a topical medication that requires a prescription. If treatment is
interrupted, the issue may reoccur, but the same treatment can be resumed as
necessary. In September 2021, The United States Food & Drug Administration
(U.S. FDA) has granted final approval to Glenmark Pharmaceuticals Ltd.
(Glenmark) for their Clindamycin Phosphate Foam, 1%, which is the generic
equivalent of Mylan Pharmaceuticals Inc.'s Evoclin®1 Foam, 1%. Glenmark
Pharmaceuticals Ltd. (GPL) is a research-driven global pharmaceutical company
operating in over 50 countries, engaged in Generics, Specialty, and OTC
businesses. Glenmark's primary therapeutic areas of focus on a global scale
include respiratory, dermatology, and oncology. Variability
in patient response to treatment is a challenge in the Global Perioral
Dermatitis Treatment Market. Perioral dermatitis can affect individuals
differently. What works well for one patient may not be effective for another.
Dermatologists often need to tailor treatment plans to each patient's unique
needs, which can be challenging. There are several treatment options available
for perioral dermatitis, including topical and oral medications. Finding the
most effective treatment for a specific patient can require trial and error, as
what works best may vary from person to person. Patients may respond to
treatments at different rates. Some individuals may experience rapid
improvement, while others may require a more extended period to see results.
This variability can affect treatment compliance and patient satisfaction. Patient
response to medications can vary, and some individuals may be more sensitive to
potential side effects or allergic reactions, making the selection of
appropriate medications more challenging. Perioral dermatitis can have
different triggers for different individuals. Identifying and avoiding these
triggers can be a key part of treatment, but it can be complex when triggers
vary from one patient to another. The variability in patient response can also
be related to how well patients adhere to treatment plans. Some patients may
not follow prescribed regimens consistently, which can impact the effectiveness
of treatment.
Global Perioral
Dermatitis Treatment Market is segmented based on Diagnosis, Treatment, End
User, and by region. Based on the
Diagnosis, Global Perioral Dermatitis Treatment Market is segmented into
Skin Biopsy, Physical
Examination, Others. A skin
biopsy is a medical procedure in which a small sample of skin tissue is removed
for examination and analysis. It is commonly performed by dermatologists or
other healthcare providers to diagnose or evaluate various skin conditions,
including rashes, growths, moles, and skin diseases. Skin biopsies are valuable
for determining the cause of skin abnormalities, identifying potential skin
cancers, and guiding treatment decisions. A punch biopsy is one of the most common
methods. It involves using a small, circular tool called a punch to remove a
cylindrical section of skin, including the epidermis, dermis, and sometimes the
subcutaneous tissue. The procedure typically begins with local anesthesia to
numb the area. After removing the skin sample, the wound may be closed with
sutures, left open to heal, or covered with a sterile dressing, depending on
the specific purpose of the biopsy. An incisional biopsy is used when only a
portion of a larger lesion is removed for analysis. It is often done to obtain
a sample of the most concerning or representative area. Local anesthesia is
usually administered, and the tissue sample is sent for laboratory examination.
Based on Region, North America held the largest share
in the Global Perioral Dermatitis Treatment Market. North America is a hub for
pharmaceutical and medical research. The presence of leading research
institutions, academic centers, and biotechnology companies fosters innovation
in the field of dermatology and skin-related conditions. Patients in North
America have relatively easy access to specialized healthcare professionals,
including dermatologists. This accessibility ensures that perioral dermatitis
cases are diagnosed and treated effectively. Health insurance coverage is
widespread in North America, and this can facilitate access to medical care,
including the treatment of dermatological conditions. The region often has a
well-informed patient population that actively seeks medical treatment for
various skin conditions, including perioral dermatitis. This drives demand for
treatments and contributes to the market's dominance.
Some of the major companies operating in
the Global
Perioral Dermatitis Treatment Market include:
- Pfizer Inc.
- Novartis International AG
- Johnson & Johnson
- Roche Holding AG
- Merck & Co., Inc.
- GlaxoSmithKline plc
- AstraZeneca plc
- Sanofi SA
- AbbVie Inc.
- Gilead Sciences, Inc.
Download Free Sample Report
Customers
can also request for 10% free customization on this report.
“Certain
areas, particularly in North America, are projected to exert significant demand
for Perioral Dermatitis Treatment. The growth in the competitive landscape and
the presence of well-established companies in the market, committed to enhance
the overall wellbeing of people each year, are expected to contribute to a
remarkable growth of the Global Perioral Dermatitis Treatment Market in the
forecast period," said Mr. Karan Chechi, Research Director with TechSci
Research, a research-based Global management consulting firm.
Perioral Dermatitis Treatment Market by Diagnosis (Skin
Biopsy, Physical Examination, Others), By Treatment (Antibiotics, Topical
Ivermectin, Immunosuppressive Agents, Others), By End User (Ambulatory Surgical
Centers, Hospitals & Clinics, Others), By Region, By Competition Forecast & Opportunities, 2018-2028F has evaluated the future growth potential of Global
Perioral Dermatitis Treatment Market and provides statistics & information
on market size, structure, and future market growth. The report intends to
provide innovative market intelligence and help decision makers take sound
investment decisions. Besides, the report also identifies and analyzes the
emerging trends along with essential drivers, challenges, and opportunities in Global
Perioral Dermatitis Treatment Market.
Contact
Techsci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +13322586602
Email: [email protected]
Website: www.techsciresearch.com